Lumanity will be attending and presenting during the 2026 European Society of Cardiology meeting.
Poster Presentations:
“Alirocumab use and MACE incidence in patients with ASCVD without prior MI or stroke: a target trial emulation with 5-year follow-up.”
“OPTIMUS RISK: Characteristics and Risk Patterns of MACE in Patients With ASCVD Without Prior Ischemic Events”
Meet with our staff, Anna Newton and Anna Marsa Florensa during the meeting. Reach out to schedule a time to meet at the conference at contact@lumanity.com.